Expression of human beta-defensin after endoscopic sinus surgery for chronic sinusitis.
- Author:
Chu-zhi XIAO
1
;
Guang-xiang HE
;
Wei-guang DENG
;
Hai-ying ZHANG
;
Wen SUN
Author Information
- Publication Type:Journal Article
- MeSH: Case-Control Studies; Chronic Disease; Endoscopy; Humans; Nasal Mucosa; metabolism; Postoperative Period; Prognosis; RNA, Messenger; genetics; Sinusitis; metabolism; surgery; beta-Defensins; metabolism
- From: Journal of Southern Medical University 2010;30(7):1580-1583
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the expressions of human beta-defensin 1 and 2 (hBD-1 and hBD-2) in nasal mucosa before and after the endoscopic sinus surgery and investigate the effects of hBD-1 and hBD-2 on the healing process after the surgery.
METHODSThe patients undergoing endoscopic sinus surgery for chronic sinusitis were divided into 3 groups according to the response to the surgery, namely cured group, response group and non-response group. With those from healthy control subjects as the control, nasal mucosa samples were collected from the patients at 1 week, 2 weeks, 1 month, 3 months and 6 months after the surgery for detection of hBD-1 and hBD-2 mRNA and protein expressions by RT-PCR and Western blotting.
RESULTShBD-1 and hBD-2 were expressed in both normal and chronic sinusitis mucosa, but the expression levels varied significantly between the individuals. The expression levels of hBD-2 was significantly correlated to the patients' response to the surgical treatment (P<0.05). hBD-1 showed slight differences between the individuals, but was not associated with the patients' prognosis.
CONCLUSIONThe expressions of hBD-2 mRNA and protein are significantly increased in patients with good response to endoscopic sinus surgery for chronic sinusitis, suggesting the value of hBD-2 as an indicator of the patients' prognosis.